799派姆单抗联合方案在一线复发/转移性头颈部鳞状细胞癌中的实际应用

Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI:10.1136/jitc-2022-sitc2022.0799

C. Black, Liya Wang, K. Ramakrishnan, D. Goto

{"title":"799派姆单抗联合方案在一线复发/转移性头颈部鳞状细胞癌中的实际应用","authors":"C. Black, Liya Wang, K. Ramakrishnan, D. Goto","doi":"10.1136/jitc-2022-sitc2022.0799","DOIUrl":null,"url":null,"abstract":"799 Table 1 Real-World Time on Treatment Results http://dx.doi.org/10.1136/jitc-2022-SITC2022.0799 Abstracts A832 J Immunother Cancer 2022;10(Suppl 2):A1–A1603 on Jne 2, 2023 by gest. P rocted by coright. http/jitc.bm jcom / J Im m unther C acer: frst pulished as 10.11jitc-2022-S IT C 20.0799 on 7 N ovem er 222. D ow nladed fom","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"209 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"799 Real-world use of pembrolizumab combination regimens in first-line recurrent/metastatic head and neck squamous cell carcinoma\",\"authors\":\"C. Black, Liya Wang, K. Ramakrishnan, D. Goto\",\"doi\":\"10.1136/jitc-2022-sitc2022.0799\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"799 Table 1 Real-World Time on Treatment Results http://dx.doi.org/10.1136/jitc-2022-SITC2022.0799 Abstracts A832 J Immunother Cancer 2022;10(Suppl 2):A1–A1603 on Jne 2, 2023 by gest. P rocted by coright. http/jitc.bm jcom / J Im m unther C acer: frst pulished as 10.11jitc-2022-S IT C 20.0799 on 7 N ovem er 222. D ow nladed fom\",\"PeriodicalId\":398566,\"journal\":{\"name\":\"Regular and Young Investigator Award Abstracts\",\"volume\":\"209 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regular and Young Investigator Award Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jitc-2022-sitc2022.0799\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2022-sitc2022.0799","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

799表1治疗结果的真实世界时间http://dx.doi.org/10.1136/jitc-2022-SITC2022.0799摘要A832 J Immunother Cancer 2022;10(增刊2):A1-A1603, 2023年6月2日。P由赖特保护。http /宗旨。jj.com / jim m unther C acer:首次发布为10.11 jtc -2022- sit C 20.0799，发布于7月22日。我们从

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

799 Real-world use of pembrolizumab combination regimens in first-line recurrent/metastatic head and neck squamous cell carcinoma

799 Table 1 Real-World Time on Treatment Results http://dx.doi.org/10.1136/jitc-2022-SITC2022.0799 Abstracts A832 J Immunother Cancer 2022;10(Suppl 2):A1–A1603 on Jne 2, 2023 by gest. P rocted by coright. http/jitc.bm jcom / J Im m unther C acer: frst pulished as 10.11jitc-2022-S IT C 20.0799 on 7 N ovem er 222. D ow nladed fom

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Regular and Young Investigator Award Abstracts

自引率

0.00%

发文量